Shots:
- The US FDA has granted 510(k) clearance to CardioTag device for assessing cardiac function
- Upon regulatory approval for the PCWP Analysis Software, the algorithm will be integrated with the CardioTag device for advanced heart failure management, following a multicenter study showing its PCWP value estimates matched implantable hemodynamic sensor accuracy in HFrEF pts; data was published in The JACC: Heart Failure & presented atAHA’24
- CardioTag device is a multimodal wearable sensor that captures high-fidelity ECG, PPG, & SCG signals, with the company planning to initiate pilot programs pairing it with AI algorithms to analyze these signals for advanced cardiac monitoring
Ref: Businesswire | Image: Carrdiosense | Press Release
Related News:- Minnesota Medical Technologies Receives the US FDA’s 510(k) Clearance for StaySure to Manage Fecal Incontinence
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
